Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 428

Similar articles for PubMed (Select 15308367)

1.

Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.

Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P.

Vaccine. 2004 Sep 3;22(25-26):3419-26.

PMID:
15308367
2.

Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P.

Vaccine. 2004 Jan 2;22(3-4):475-84.

PMID:
14670330
3.

Impact of the 1996-1997 supplementary measles vaccination campaigns in South Africa.

Uzicanin A, Eggers R, Webb E, Harris B, Durrheim D, Ogunbanjo G, Isaacs V, Hawkridge A, Biellik R, Strebel P.

Int J Epidemiol. 2002 Oct;31(5):968-76.

4.

Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.

Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.

Vaccine. 2013 May 31;31(24):2661-6. doi: 10.1016/j.vaccine.2013.04.014. Epub 2013 Apr 17.

PMID:
23602654
5.

A benefit-cost analysis of two-dose measles immunization in Canada.

Pelletier L, Chung P, Duclos P, Manga P, Scott J.

Vaccine. 1998 May-Jun;16(9-10):989-96.

PMID:
9682349
6.

Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.

Otten MW Jr, Okwo-Bele JM, Kezaala R, Biellik R, Eggers R, Nshimirimana D.

J Infect Dis. 2003 May 15;187 Suppl 1:S36-43.

7.

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.

Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.

J Infect Dis. 2004 May 1;189 Suppl 1:S131-45.

8.

Measles epidemiology and outbreak response immunization in a rural community in Peru.

Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chiu MC.

Bull World Health Organ. 1999;77(7):545-52.

9.

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.

10.

Progress toward measles elimination--Southern Africa, 1996-1998.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Jul 16;48(27):585-9.

11.

Impact of mass measles campaigns among children less than 5 years old in Uganda.

Nanyunja M, Lewis RF, Makumbi I, Seruyange R, Kabwongera E, Mugyenyi P, Talisuna A.

J Infect Dis. 2003 May 15;187 Suppl 1:S63-8.

12.

Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.

Chuang SK, Lau YL, Lim WL, Chow CB, Tsang T, Tse LY.

Bull World Health Organ. 2002;80(7):585-91. Epub 2002 Jul 30.

13.

[Cost-effectiveness analysis on two different measles immunization strategies].

Wu H, Wang K, Zhang X, Jin S, Feng Z.

Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Apr;21(2):121-3. Chinese.

PMID:
11860771
14.

Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign.

Bernhardt GL, Cameron NA, Willems B, Boulle A, Coetzee D.

S Afr Med J. 2013 Jan 24;103(3):181-6. doi: 10.7196/samj.6196.

PMID:
23472696
15.

Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011.

Ntshoe GM, McAnerney JM, Archer BN, Smit SB, Harris BN, Tempia S, Mashele M, Singh B, Thomas J, Cengimbo A, Blumberg LH, Puren A, Moyes J, van den Heever J, Schoub BD, Cohen C.

PLoS One. 2013;8(2):e55682. doi: 10.1371/journal.pone.0055682. Epub 2013 Feb 20.

16.

Progress in measles and rubella elimination in Iran.

Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.

Pediatr Infect Dis J. 2007 Dec;26(12):1137-41.

PMID:
18043452
17.

[Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].

Wichmann O, Ultsch B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1260-9. doi: 10.1007/s00103-013-1801-7. Review. German.

PMID:
23990088
18.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
19.

Cost-effectiveness of supplementary immunization for measles in India.

Dabral M.

Indian Pediatr. 2009 Nov;46(11):957-62. Epub 2009 May 20.

20.

Measles incidence before and after mass vaccination campaigns in Burkina Faso.

Kambiré C, Konde MK, Yaméogo A, Tiendrébéogo SR, Ouédraogo RT, Otten MW Jr, Cairns KL, Zuber PL.

J Infect Dis. 2003 May 15;187 Suppl 1:S80-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk